Australia · Delayed Price · Currency is AUD Clinuvel Pharmaceuticals Statistics
Total Valuation
ASX:CUV has a market cap or net worth of AUD 503.77 million. The enterprise value is 271.10 million.
| Market Cap | 503.77M |
| Enterprise Value | 271.10M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Sep 4, 2025 |
Share Statistics
ASX:CUV has 50.43 million shares outstanding. The number of shares has increased by 0.37% in one year.
| Current Share Class | 50.43M |
| Shares Outstanding | 50.43M |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 10.21% |
| Owned by Institutions (%) | 22.85% |
| Float | 41.79M |
Valuation Ratios
The trailing PE ratio is 15.52 and the forward PE ratio is 13.49. ASX:CUV's PEG ratio is 2.87.
| PE Ratio | 15.52 |
| Forward PE | 13.49 |
| PS Ratio | 5.23 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | 12.57 |
| P/OCF Ratio | 12.45 |
| PEG Ratio | 2.87 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.16, with an EV/FCF ratio of 6.76.
| EV / Earnings | 8.33 |
| EV / Sales | 2.82 |
| EV / EBITDA | 6.16 |
| EV / EBIT | 6.30 |
| EV / FCF | 6.76 |
Financial Position
The company has a current ratio of 14.64, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.64 |
| Quick Ratio | 13.98 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 8.53 |
Financial Efficiency
Return on equity (ROE) is 13.96% and return on invested capital (ROIC) is 193.72%.
| Return on Equity (ROE) | 13.96% |
| Return on Assets (ROA) | 10.62% |
| Return on Invested Capital (ROIC) | 193.72% |
| Return on Capital Employed (ROCE) | 17.07% |
| Weighted Average Cost of Capital (WACC) | 8.31% |
| Revenue Per Employee | 6.02M |
| Profits Per Employee | 2.03M |
| Employee Count | 16 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.12 |
Taxes
In the past 12 months, ASX:CUV has paid 11.66 million in taxes.
| Income Tax | 11.66M |
| Effective Tax Rate | 26.38% |
Stock Price Statistics
The stock price has decreased by -0.79% in the last 52 weeks. The beta is 0.61, so ASX:CUV's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -0.79% |
| 50-Day Moving Average | 9.28 |
| 200-Day Moving Average | 10.80 |
| Relative Strength Index (RSI) | 59.94 |
| Average Volume (20 Days) | 108,972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CUV had revenue of AUD 96.30 million and earned 32.54 million in profits. Earnings per share was 0.64.
| Revenue | 96.30M |
| Gross Profit | 86.32M |
| Operating Income | 43.00M |
| Pretax Income | 44.20M |
| Net Income | 32.54M |
| EBITDA | 43.68M |
| EBIT | 43.00M |
| Earnings Per Share (EPS) | 0.64 |
Balance Sheet
The company has 233.00 million in cash and 323,843 in debt, with a net cash position of 232.68 million or 4.61 per share.
| Cash & Cash Equivalents | 233.00M |
| Total Debt | 323,843 |
| Net Cash | 232.68M |
| Net Cash Per Share | 4.61 |
| Equity (Book Value) | 249.02M |
| Book Value Per Share | 4.96 |
| Working Capital | 243.53M |
Cash Flow
In the last 12 months, operating cash flow was 40.47 million and capital expenditures -390,176, giving a free cash flow of 40.08 million.
| Operating Cash Flow | 40.47M |
| Capital Expenditures | -390,176 |
| Depreciation & Amortization | 678,872 |
| Net Borrowing | -200,481 |
| Free Cash Flow | 40.08M |
| FCF Per Share | 0.79 |
Margins
Gross margin is 89.63%, with operating and profit margins of 44.65% and 33.79%.
| Gross Margin | 89.63% |
| Operating Margin | 44.65% |
| Pretax Margin | 45.90% |
| Profit Margin | 33.79% |
| EBITDA Margin | 45.36% |
| EBIT Margin | 44.65% |
| FCF Margin | 41.62% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.70% |
| Buyback Yield | -0.37% |
| Shareholder Yield | 0.13% |
| Earnings Yield | 6.46% |
| FCF Yield | 7.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ASX:CUV is 22.91, which is 129.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 22.91 |
| Price Target Difference | 129.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 11.62% |
| EPS Growth Forecast (3Y) | 10.42% |
Stock Splits
The last stock split was on November 12, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 12, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:CUV has an Altman Z-Score of 18.96 and a Piotroski F-Score of 6.
| Altman Z-Score | 18.96 |
| Piotroski F-Score | 6 |